Suven Pharmaceuticals Share Price

ABOUT Suven Pharmaceuticals

• Industry Biotechnology & Drugs
• ISIN INE03QK01018
• BSE Code 543064
• NSE Code COHANCE

Cohance Lifesciences Limited, formerly Suven Pharmaceuticals Limited, is an India-based technology-driven contract development and manufacturing organization (CDMO), providing integrated solutions in custom synthesis, process research and development (R&D), and manufacturing. The Company’s business units include pharmaceutical CDMO, specialty chemical CDMO, and active pharmaceutical ingredient (API) (including formulations). Its integrated CDMO model enables comprehensive molecule development and life cycle management for both pharmaceutical and specialty chemical partners. Its custom synthesis services include design and synthesis, synthesis of complex molecules, synthesis of reference standards, synthesis of impurities and metabolites, scale-up of existing synthetic routes, and process optimization and backward integration. Its process research services include route scouting, process development, process safety evaluation, analytical method development, and regulatory support.

MANAGEMENT

• Vivek Sharma Additional Executive Chairman of the Board
• Sudhir Singh Chief Executive Officer
• Himanshu Agarwal Chief Financial Officer
• Gaurav Bahadur Chief Human Resources Officer
• Kundan Jha Compliance Officer and Company Secretary
• Vetukuri Venkata Prasada Raju Managing Director, Executive Director